Overview
Christopher Deig, MD, prioritizes making his patients feel heard, respected and empowered to make their own medical decisions. He wants patients to always feel comfortable asking questions to understand their treatment and alternative options. Dr. Deig is passionate about radiation oncology and ensuring every patient is offered the best treatment available for their condition. He believes in integrating modern technology with the goal of making treatment more convenient and effective while reducing patients’ side effects.Dr. Deig studied biology, chemistry and history at Wabash College in Indiana before completing medical school at Indiana University School of Medicine. He completed post-doctoral radiobiology research studying blood tests that can help detect and monitor for cancer. Dr. Deig also completed a transitional medicine internship at Presbyterian St. Luke's Medical Center in Denver before his formal training in radiation oncology at Oregon Health & Science University. During this time, he gained extensive experience in advanced radiotherapy techniques including brachytherapy, radiosurgery and integration of new technologies, including artificial intelligence.Dr. Deig has published over 20 peer-reviewed research articles covering topics including head and neck, pancreatic, liver and lung cancers. He has also designed a randomized controlled trial for liver cancer in training and is motivated to integrate the newest data and radiotherapy techniques into his daily practice.In his free time, Dr. Deig loves camping, hiking, photography, running, and spending time outdoors with his wife and children.
Dr. Deig is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Prostate Cancer.
His clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Non-Small Cell Lung Cancer (NSCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
14300 Orchard Pkwy, Westminster, CO 80023
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rocky Mountain Cancer Centers LLP - Thornton Radiation
Marie Weeks is a Radiation Oncologist in Thornton, Colorado. Dr. Weeks is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Anal Cancer, and Posterior Fossa Tumor. Dr. Weeks is currently accepting new patients.
Poudre Valley Medical Group LLC
Suraj Singh is a Radiation Oncologist in Castle Rock, Colorado. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).
Laurie Gaspar is a Radiation Oncologist in Greeley, Colorado. Dr. Gaspar is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Metastatic Brain Tumor, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerDr. Deig isAdvanced. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Deig isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Deig isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Deig isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Deig isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Deig isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)